Albemarle
ALB
79.70
-3.23
-3.89%
Albemarle
US · ALB
#1279 by market cap
Listed 1970
79.70
-3.23
-3.89%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
C-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
6 1
■ Upgrades■ Downgrades
- 6 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Mizuho Securities moved from Hold to Buy on 2026-10-13.
Analyst consensus 14 analysts
Buy
Avg price target 140.07 +75.7%
Price target rangecurrent 79.70
Low105.00
Avg140.07
High211.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-13 | DBS | -- | Buy | 135.00 |
| 2026-11-12 | BofA Securities | -- | Buy | 120.00 |
| 2026-11-11 | BofA Securities | -- | Buy | 120.00 |
| 2026-11-09 | UBS | -- | Buy | 137.00 |
| 2026-11-09 | Scotiabank | -- | Buy | 165.00 |
| 2026-11-09 | Morgan Stanley | -- | Hold | 105.00 |
| 2026-11-09 | Deutsche Bank | -- | Buy | 125.00 |
| 2026-11-09 | Citi | -- | Buy | 140.00 |
| 2026-11-06 | Truist Financial | -- | Buy | 170.00 |
| 2026-11-06 | BMO Capital | -- | Buy | 160.00 |
| 2026-11-05 | Scotiabank | -- | Buy | 190.00 |
| 2026-11-05 | RBC Capital | -- | Buy | 119.00 |
| 2026-10-22 | Citi | -- | Buy | 125.00 |
| 2026-10-20 | Truist Financial | -- | Buy | 185.00 |
| 2026-10-19 | BofA Securities | -- | Buy | 131.00 |
| 2026-10-15 | RBC Capital | -- | Buy | 129.00 |
| 2026-10-13 | Mizuho Securities | -- | Buy | 130.00 |
| 2026-10-12 | Barclays | -- | Hold | 109.00 |
| 2026-10-08 | Morgan Stanley | -- | Hold | 161.00 |
| 2026-10-07 | Morgan Stanley | -- | Hold | 161.00 |
| 2026-10-06 | Argus Research | -- | Buy | 135.00 |
| 2026-10-06 | BMO Capital | -- | Buy | 175.00 |
| 2026-10-05 | UBS | -- | Buy | 150.00 |
| 2026-10-01 | Mizuho Securities | -- | Hold | 130.00 |
| 2026-09-30 | Mizuho Securities | -- | Hold | 130.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-13 | Mizuho Securities | Hold → Buy | 130.00 |
| 2026-06-18 | Citi | Hold → Buy | 225.00 |
| 2026-05-08 | Baird | Buy → Hold | 236.00 |
| 2026-02-17 | BofA Securities | Hold → Buy | 190.00 |
| 2026-01-21 | Truist Financial | Hold → Buy | 205.00 |
| 2026-01-07 | Baird | Sell → Buy | 210.00 |
| 2025-12-15 | Morgan Stanley | Sell → Hold | 147.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | After close | ±6.04% | +3.58% (in line) |
| 2026/Q2 | 2026-08-05 | After close | ±6.50% | +5.54% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±6.24% | +2.98% (in line) |
| 2025/Q4 | 2026-02-11 | After close | ±6.64% | -9.41% (beat) |
| 2025/Q3 | 2025-11-05 | After close | ±5.77% | -0.76% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±7.05% | -1.51% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±6.51% | +1.32% (in line) |
| 2024/Q4 | 2025-02-12 | After close | ±7.36% | +3.46% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±8.02% | +3.47% (in line) |
| 2024/Q2 | 2024-07-31 | After close | ±7.57% | -0.53% (in line) |
| 2024/Q1 | 2024-05-01 | After close | ±7.25% | +5.29% (in line) |
| 2023/Q4 | 2024-02-14 | After close | ±10.08% | +2.72% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:16 · For reference only, not investment advice and not tailored to your situation.
Albemarle discussion 0 comments